-
-
-
-
-
-
-
Bausch + Lomb sets three-year growth targets at investor day
-
-
-
-
-
-
-
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
-
-
-
-
-
-
-
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
-
-
-
-
-
-
-
Bausch Health Announces First Quarter 2024 Results
-
-
-
-
-
-
-
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
-
-
-
-
-
-
-
Bausch Health (BHC) Announces Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer
-
-
-
-
-
-
-
Glenview Capital Management, Owner of 6% of Bausch Health Companies Inc., (BHC) Publicly Releases Letter to CEO, Joe Papa, Calls for Spinoff
-
1,158,021 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

